These results show that survivin prevented the alterations in carbohydrate metabolism seen in the BIRC5hi CD4+ cells from patients with RA (Figure 1F) but did not alter the mRNA levels of HIF1A or its metabolic targets HK2, ALDOA, ENO1, and GAPDH (Figure S2A). Here, CD4 is linked to rheumatoid arthritis.